Search clinical trials for: Dupilumab (SAR231893/REGN668)
Total 257 results
-
Regeneron PharmaceuticalsSanofiCompletedAtopic DermatitisGermany, Poland, United Kingdom, Hungary, Canada, Czechia
-
Regeneron PharmaceuticalsSanofiActive, not recruitingAtopic DermatitisUnited States, Canada, Czechia, Germany, Hungary, Poland, United Kingdom
-
Regeneron PharmaceuticalsAvailableBullous Pemphigoid | Pediatric Asthma | Pediatric Eosinophilic Esophagitis (EoE) | Pediatric and Adolescent Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
-
Regeneron PharmaceuticalsSanofiCompletedAtopic DermatitisPoland, Germany, France, Hungary, Czechia
-
Regeneron PharmaceuticalsSanofiCompletedAtopic DermatitisUnited States, Germany, Poland, Japan, Canada, Hungary, Czechia
-
Regeneron PharmaceuticalsSanofiCompleted
-
Regeneron PharmaceuticalsSanofiActive, not recruitingEosinophilic Esophagitis (EoE)United States, Canada
-
Regeneron PharmaceuticalsSanofiCompletedAllergic Bronchopulmonary AspergillosisUnited States, Hungary, Bulgaria, France, Germany, Japan, Netherlands, Poland, Romania, United Kingdom
-
Regeneron PharmaceuticalsSanofiCompletedAtopic DermatitisHungary, Netherlands, Spain, United Kingdom, United States, Australia, Austria, Belgium, Bulgaria, Canada, China, Czechia, Denmark, Estonia, Finland, France, Germany, Ireland, Italy, Japan, Korea, Republic of, Lithuania, New Zealand, ... and more
-
Regeneron PharmaceuticalsSanofiAvailableBullous Pemphigoid
-
Regeneron PharmaceuticalsSanofiCompletedConjunctivitis | Atopic DermatitisUnited States
-
Regeneron PharmaceuticalsSanofiActive, not recruitingChronic Rhinosinusitis With Nasal PolyposisUnited States, Italy, Canada, Japan, Germany, Netherlands
-
Regeneron PharmaceuticalsSanofiActive, not recruitingAsthmaUnited States, United Kingdom, Canada, France, Puerto Rico, Japan, Spain, Denmark, Italy, Sweden
-
Regeneron PharmaceuticalsSanofiCompletedPeanut AllergyUnited States, Canada
-
Regeneron PharmaceuticalsSanofiRecruitingAsthma | Atopic Dermatitis (AD)United States
-
Regeneron PharmaceuticalsSanofiRecruitingAtopic Dermatitis | Adverse Pregnancy OutcomesUnited States
-
SanofiRegeneron PharmaceuticalsCompleted
-
SanofiRegeneron PharmaceuticalsCompletedChronic Rhinosinusitis With Nasal PolypsJapan
-
Regeneron PharmaceuticalsSanofiCompletedAtopic DermatitisUnited States
-
SanofiRegeneron PharmaceuticalsCompletedDermatitis AtopicUnited States, United Kingdom
-
SanofiRegeneron PharmaceuticalsCompletedHealthy VolunteersUnited States
-
SanofiRegeneron PharmaceuticalsCompletedDermatitis AtopicUnited States, Germany
-
SanofiRegeneron PharmaceuticalsCompletedAtopic DermatitisUnited States, Canada
-
SanofiRegeneron PharmaceuticalsCompletedAsthmaSpain, Canada, Denmark, Belgium, Japan, Korea, Republic of, Mexico, United States, Israel, Brazil, Australia, France, Germany, United Kingdom, Argentina, Chile, Colombia, Hungary, Italy, Netherlands, Poland, Romania, Russian Federation and more
-
SanofiRegeneron PharmaceuticalsActive, not recruitingDermatitis AtopicSpain, Czechia, Italy, Israel, Argentina, Australia, Austria, Belgium, Colombia, Finland, France, Greece, Japan, Kuwait, Mexico, Netherlands, Norway, Portugal, Russian Federation, Saudi Arabia, Taiwan, United Arab Emirates
-
Regeneron PharmaceuticalsSanofiCompletedEosinophilic EsophagitisUnited States, Australia, Belgium, Canada, France, Germany, Italy, Netherlands, Spain, Sweden, Switzerland, United Kingdom
-
Regeneron PharmaceuticalsSanofiCompletedModerate to Severe Atopic Hand and Foot DermatitisUnited States, Germany, Japan, Poland
-
SanofiRegeneron PharmaceuticalsCompletedAsthmaUnited States, Argentina, Belgium, Canada, France, Germany, Israel, Japan, Netherlands, South Africa
-
Regeneron PharmaceuticalsSanofiCompletedEosinophilic EsophagitisUnited States
-
Regeneron PharmaceuticalsSanofiCompletedDermatitis, AtopicUnited States, Germany, Poland, United Kingdom
-
Regeneron PharmaceuticalsSanofiCompletedAtopic DermatitisGermany, New Zealand, Australia
-
Regeneron PharmaceuticalsSanofiCompletedDermatitis, AtopicUnited States, France, Poland, United Kingdom, Germany, Hong Kong, Canada, Korea, Republic of, Italy, Lithuania, Sweden
-
Regeneron PharmaceuticalsSanofiCompletedDermatitis, AtopicUnited States, Germany, Spain, Bulgaria, Japan, Canada, Denmark, Finland, Singapore, Estonia
-
SanofiRegeneron PharmaceuticalsCompleted
-
Regeneron PharmaceuticalsSanofiCompletedStudy to Determine the Safety and Effectiveness of Dupilumab for Treatment of Atopic Dermatitis (AD)Atopic Dermatitis (AD)United States, Canada
-
Regeneron PharmaceuticalsSanofiCompletedAtopic DermatitisGermany, Poland, Belgium, Netherlands, Russian Federation, Ireland, United Kingdom, Slovakia, Austria, Spain
-
Regeneron PharmaceuticalsSanofiRecruitingEosinophilic Gastritis | Eosinophilic Duodenitis | Eosinophilic Gastrointestinal DiseaseUnited States, Japan, Poland, Italy, Australia
-
Regeneron PharmaceuticalsSanofiActive, not recruitingDermatitis, AtopicUnited States, Canada
-
Regeneron PharmaceuticalsSanofiCompletedAtopic DermatitisUnited States, Italy, United Kingdom, Spain, Japan, Canada, Netherlands, New Zealand, Hungary, Czechia, Poland, Australia, Romania, Korea, Republic of
-
SanofiRegeneron PharmaceuticalsRecruiting
-
SanofiRegeneron PharmaceuticalsCompletedAsthmaSpain, Mexico, United States, Hungary, Italy, Argentina, Australia, Brazil, Canada, Chile, Colombia, Lithuania, Poland, Romania, Russian Federation, South Africa, Turkey, Ukraine
-
SanofiRegeneron PharmaceuticalsCompleted
-
Regeneron PharmaceuticalsSanofiCompletedAllergic RhinitisUnited States, Canada
-
Regeneron PharmaceuticalsSanofiCompletedDermatitis, AtopicUnited States, Germany, Poland, Canada, Czechia, United Kingdom
-
Regeneron PharmaceuticalsSanofiActive, not recruitingBullous PemphigoidUnited States, Japan, Germany, Australia, France, Israel, Poland, Spain, Taiwan
-
SanofiRegeneron PharmaceuticalsCompleted
-
Regeneron PharmaceuticalsCompletedAsthmaUnited States, Spain, France, Germany, Poland
-
SanofiRegeneron PharmaceuticalsCompletedChronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP)Belgium, Mexico, Turkey, Israel, Spain, Sweden, Argentina, Canada, Japan, United States, Australia, Chile, Portugal, Russian Federation